0001209191-23-050295.txt : 20230921 0001209191-23-050295.hdr.sgml : 20230921 20230921165713 ACCESSION NUMBER: 0001209191-23-050295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230920 FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iadonato Shawn CENTRAL INDEX KEY: 0001958184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 231269617 MAIL ADDRESS: STREET 1: C/O KINETA, INC. STREET 2: 219 TERRY AVE. N., SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KINETA, INC./DE CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: (206) 378-0400 MAIL ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-20 0 0001445283 KINETA, INC./DE KA 0001958184 Iadonato Shawn C/O KINETA, INC. 219 TERRY AVE. N., SUITE 300 SEATTLE WA 98109 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-09-20 4 P 0 10000 2.5042 A 670230 D Common Stock 8553 I By IRA The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.455 to $2.580, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Pauline Kenny, as Attorney-in-Fact 2023-09-21